IL216581A - Aminopyrazole Triazolothiadiazole Compounds, Preparations Containing and Using - Google Patents

Aminopyrazole Triazolothiadiazole Compounds, Preparations Containing and Using

Info

Publication number
IL216581A
IL216581A IL216581A IL21658111A IL216581A IL 216581 A IL216581 A IL 216581A IL 216581 A IL216581 A IL 216581A IL 21658111 A IL21658111 A IL 21658111A IL 216581 A IL216581 A IL 216581A
Authority
IL
Israel
Prior art keywords
triazolothiadiazole
aminopyrazole
compositions
compounds
same
Prior art date
Application number
IL216581A
Other languages
English (en)
Hebrew (he)
Other versions
IL216581A0 (en
Original Assignee
Vertex Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42346870&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL216581(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vertex Pharma filed Critical Vertex Pharma
Publication of IL216581A0 publication Critical patent/IL216581A0/en
Publication of IL216581A publication Critical patent/IL216581A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL216581A 2009-05-28 2011-11-24 Aminopyrazole Triazolothiadiazole Compounds, Preparations Containing and Using IL216581A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18178609P 2009-05-28 2009-05-28
PCT/US2010/036312 WO2010138665A1 (en) 2009-05-28 2010-05-27 Aminopyrazole triazolothiadiazole inhibitors of c-met protien kinase

Publications (2)

Publication Number Publication Date
IL216581A0 IL216581A0 (en) 2012-02-29
IL216581A true IL216581A (en) 2014-02-27

Family

ID=42346870

Family Applications (1)

Application Number Title Priority Date Filing Date
IL216581A IL216581A (en) 2009-05-28 2011-11-24 Aminopyrazole Triazolothiadiazole Compounds, Preparations Containing and Using

Country Status (25)

Country Link
EP (1) EP2435443B1 (OSRAM)
JP (1) JP5686796B2 (OSRAM)
KR (1) KR20120030110A (OSRAM)
CN (1) CN102459283B (OSRAM)
AR (1) AR076617A1 (OSRAM)
AU (1) AU2010254055B2 (OSRAM)
BR (1) BRPI1012037A2 (OSRAM)
CA (1) CA2762190A1 (OSRAM)
CL (1) CL2011002946A1 (OSRAM)
DK (1) DK2435443T3 (OSRAM)
ES (1) ES2433090T3 (OSRAM)
HR (1) HRP20130986T1 (OSRAM)
IL (1) IL216581A (OSRAM)
MX (1) MX2011012521A (OSRAM)
NZ (1) NZ596616A (OSRAM)
PL (1) PL2435443T3 (OSRAM)
PT (1) PT2435443E (OSRAM)
RS (1) RS53011B (OSRAM)
RU (1) RU2552993C2 (OSRAM)
SG (1) SG176574A1 (OSRAM)
SI (1) SI2435443T1 (OSRAM)
TW (1) TWI491614B (OSRAM)
UA (1) UA106082C2 (OSRAM)
WO (1) WO2010138665A1 (OSRAM)
ZA (1) ZA201108655B (OSRAM)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2435444A1 (en) * 2009-05-28 2012-04-04 Vertex Pharmaceuticals Incorporated Substituted pyrazole inhibitors of c-met protein kinase
US8263777B2 (en) 2010-05-27 2012-09-11 Vertex Pharmaceuticals Incorporated Aminopyrazole triazolothiadiazole inhibitor of c-Met protein kinase
TR201113223A2 (tr) * 2011-12-29 2012-06-21 Koçak Farma İlaç Ve Ki̇mya Sanayi̇ A. Ş. Pemetrekset disodyum hazırlanmasına yönelik tek basamaklı işlem.
KR101373912B1 (ko) 2012-03-26 2014-03-13 중앙대학교 산학협력단 Ｓｈｐ－2의 활성을 특이적으로 저해하는 조성물 및 이의 제조방법
CN106924260B (zh) * 2015-12-31 2018-05-25 北京浦润奥生物科技有限责任公司 化合物在制备用于治疗脑胶质瘤的药物中的用途
CN109897054B (zh) * 2017-12-08 2021-12-10 中国药科大学 三唑并噻二唑类c-Met激酶抑制剂的制备方法及其用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5304121A (en) 1990-12-28 1994-04-19 Boston Scientific Corporation Drug delivery system making use of a hydrogel polymer coating
US5716981A (en) 1993-07-19 1998-02-10 Angiogenesis Technologies, Inc. Anti-angiogenic compositions and methods of use
US6099562A (en) 1996-06-13 2000-08-08 Schneider (Usa) Inc. Drug coating with topcoat
CN1863780A (zh) * 2002-08-14 2006-11-15 沃泰克斯药物股份有限公司 蛋白激酶抑制剂及其应用
US7122548B2 (en) * 2003-07-02 2006-10-17 Sugen, Inc. Triazolotriazine compounds and uses thereof
JO2629B1 (en) * 2004-08-19 2012-06-24 افينتيس فارما سوتيكالز انك Branched carboxylic acid amides containing thienobirol, carboxylic acid amides containing pyrolithiazole, and the like as kinase inhibitors casein epsilon
CA2630884A1 (en) * 2005-11-30 2007-06-07 Vertex Pharmaceuticals Incorporated Inhibitors of c-met and uses thereof
ZA200804681B (en) * 2005-11-30 2009-11-25 Vertex Pharma Inc Inhibitors of C-Met and uses thereof
NL2000613C2 (nl) * 2006-05-11 2007-11-20 Pfizer Prod Inc Triazoolpyrazinederivaten.
KR101156845B1 (ko) * 2007-05-21 2012-06-18 에스지엑스 파마슈티컬스, 인코포레이티드 헤테로시클릭 키나제 조절제
CN102216309B (zh) * 2008-11-19 2014-05-07 沃泰克斯药物股份有限公司 C-met蛋白激酶的三唑并噻二唑抑制剂
EP2435444A1 (en) * 2009-05-28 2012-04-04 Vertex Pharmaceuticals Incorporated Substituted pyrazole inhibitors of c-met protein kinase

Also Published As

Publication number Publication date
CA2762190A1 (en) 2010-12-02
PT2435443E (pt) 2013-10-31
WO2010138665A1 (en) 2010-12-02
KR20120030110A (ko) 2012-03-27
AU2010254055B2 (en) 2016-01-14
PL2435443T3 (pl) 2014-01-31
ZA201108655B (en) 2013-01-30
RS53011B (sr) 2014-04-30
HRP20130986T1 (hr) 2013-11-22
AR076617A1 (es) 2011-06-22
JP2012528186A (ja) 2012-11-12
SI2435443T1 (sl) 2013-12-31
CL2011002946A1 (es) 2012-07-27
NZ596616A (en) 2013-05-31
TW201100436A (en) 2011-01-01
RU2011153613A (ru) 2013-07-10
DK2435443T3 (da) 2013-10-28
CN102459283A (zh) 2012-05-16
AU2010254055A1 (en) 2011-12-15
BRPI1012037A2 (pt) 2016-05-17
SG176574A1 (en) 2012-01-30
TWI491614B (zh) 2015-07-11
ES2433090T3 (es) 2013-12-09
HK1169105A1 (en) 2013-01-18
IL216581A0 (en) 2012-02-29
EP2435443A1 (en) 2012-04-04
RU2552993C2 (ru) 2015-06-10
CN102459283B (zh) 2014-11-12
JP5686796B2 (ja) 2015-03-18
EP2435443B1 (en) 2013-07-31
MX2011012521A (es) 2012-01-30
UA106082C2 (uk) 2014-07-25

Similar Documents

Publication Publication Date Title
IL241634A0 (en) History of benzodiazepines, preparations containing them and their uses
IL220283A0 (en) 4-oxo-ih-quinoline-3- carboxamides, compositions comprising the same and uses thereof
IL220625A (en) Isoindolinone compounds, preparations containing them and their uses
IL220563A0 (en) Pteridinone compounds, compositions comprising the same and uses thereof
IL217541A0 (en) Triazolopyridine compounds, compositions comprising the same and uses thereof
AP2012006314A0 (en) Antiparistic dihydroazole compounds and compositions comprising same.
IL252561A0 (en) Antibodies against Siglac-15 polynucleotides encoding them, preparations containing them and their uses
IL210722A0 (en) Benzazepine derivatives, compositions comprising the same and uses thereof
IL220009A0 (en) Indole compounds, compositions comprising the same and uses thereof
IL208220A0 (en) Substituted imidazoquinolines, compositions comprising the same and uses thereof
IL216254A (en) Compounds, pharmaceutical compositions and their uses
IL212836A0 (en) Azaquinolinone derivatives, compositions comprising the same and uses thereof
IL221210A0 (en) Heterocyclic compounds, compositions comprising the same and uses thereof
IL216833A0 (en) Triazine derivatives, compositions comprising the same and uses thereof
IL215799A (en) Quinazolone compounds, pharmaceuticals containing them and their uses
IL216768A0 (en) Aminopyrrolidinone derivatives compositions comprising the same and uses thereof
IL216829A0 (en) Ureidophenyl substituted triazine derivatives, compositions comprising the same and uses thereof
IL212278A0 (en) Morpholinopurine derivatives, compositions comprising the same and uses thereof
IL221906B (en) pde10 suppressor compounds, preparations containing them and their uses
IL221209A0 (en) Pyrazolo piperidine derivatives, compositions comprising the same and uses thereof
IL221207A0 (en) Pyrazolo piperidine derivatives, compositions comprising the same and uses thereof
IL223405B (en) Phosphoplatins, preparations containing them and their uses
IL219243A (en) History of 5-hydroxypyrimidine-4-carboxamide, preparations containing them and their uses
IL215049A0 (en) Gpr119 agonist compound, compositions comprising the same and uses thereof
IL207639A0 (en) Pyrrolopyrimidinecarboxamide compounds, compositions comprising the same and uses thereof

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed